Evidence map›Paper›PMID 41200974›Full record

ArticleSe pu = Chinese journal of chromatography2025

[Determination of genotoxic impurity in the bulk drug of crizotinib by high performance liquid chromatography-electrospray ionization tandem mass spectrometry].

Xiao-Bing Zhan, Yi Qin, Ying Yan, Jie Zhou, Long-Shan Zhao

Abstract readEnglish Abstract
In one paragraph

Article in Se pu = Chinese journal of chromatography, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiao-Bing ZhanShenyang Pharmaceutical University,Shenyang 110016,China.
Yi QinShenyang Pharmaceutical University,Shenyang 110016,China.
Ying YanShenyang Pharmaceutical University,Shenyang 110016,China.
Jie ZhouShenyang Pharmaceutical University,Shenyang 110016,China.
Long-Shan ZhaoShenyang Pharmaceutical University,Shenyang 110016,China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A method based on high performance liquid chromatography-electrospray ionization tandem mass spectrometry (HPLC-ESI-MS/MS) was developed for the determination of the potential genotoxic impurity (WHT1408-Q2H) in the bulk drug of crizotinib. An Agilent Eclipse XDB C8 chromatographic column (150 mm×4.6 mm, 3.5 µm) was used for chromatographic separation. The mobile phases were 0.1% formic acid aqueous solution and 0.1% formic acid acetonitrile solution at a flow rate of 0.4 mL/min. The column temperature was maintained at 40 ℃ and the sample size was 5 μL. In the mass spectrometry section, the electrospray positive ion (ESI

Indexed as

Drug ContaminationMutagensPyrazolesPyridinesSpectrometry, Mass, Electrospray IonizationTandem Mass SpectrometryChromatography, High Pressure LiquidCrizotinibCrizotinibMutagensPyrazolesPyridinesgenotoxic impurityhigh performance liquid chromatography-electrospray ionization tandem mass spectrometry (HPLC-ESI-MS/MS)non-small cell lung cancerthe bulk drug of crizotinib

Identifiers

PMID41200974
PMCPMC12598549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.